Lessons learned from Hospital DOTS Linkage (HDL) in Yogyakarta Indonesia Jan Voskens MPH, KNCV GTI/UAB.

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Module 11: Community TB Care Image source: Pierre Virot, World Lung Foundation.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Improving diagnosis TB laboratory strengthening.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Role of the laboratory in disease surveillance
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
National TB Program Indonesia 1 TB Epidemic DOTS HIV Epidemic.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
1 Module PLANNING AND ORGANIZING EXTERNAL QUALITY ASSESSMENT.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
National TB/ Leprosy Programme Manager
Action Plan Prepared by : Ismat Ara Khusheed Deputy Director,PTP Sindh At JAPAN 2006 At JAPAN 2006.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
Monitoring and Evaluation Module 12 – March 2010.
Monitoring Drug Resistant Tuberculosis Treatment in Brazil through an Innovative Web-based Information System Dr. Luis Gustavo Bastos Management Sciences.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Large Hospitals DEWG – Group Work Report. Participants Indonesia Philippines South Africa Viet Nam Korea China Partners: KNCV, WHO, Gates.
June 30, 2010 TB Program Thailand MOPH – U.S. CDC Collaboration TB Project Implementation: Impact on NTP?
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
DOTS-PLUS IN TANZANIA: PREPARATION PHASE Global DOTS Expansion Working Group Meeting, Paris: 28 October 2004 NTLP - MOH Prepared by: Dr. S. M. Egwaga NTLP.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
Chapter 7.2 Examination and Treatment Prepared by Nguyen Trong Khoa.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Strengthening TB and HIV&AIDS Responses in East Central Uganda Strengthening Laboratory TB diagnostic capacity of peripheral laboratories in East Central.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Monitoring and Evaluation Frameworks
TB- HIV Collaborative activities in Romania- may 2006 status
Philippe Glaziou Geneva, 12 October 2009
ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.
Zaw Win, Tin Aung, Sun Tun Population Services International/ Myanmar
TB Control in PHC network and Partners Coordination in Cambodia
TB/HIV surveillance : Who is going to get the job done?
Find and Treat All Missing Persons with TB
Key issues in DOTS implementation
Impact of Using Fixed Dose Combinations (FDCs) versus
Public-Public Mix for DOTS Indonesia’s Experience
The role of the community in TB control
3rd Global WG on TB/HIV, Montreux, 4-6 June, 2003
Vietnam Investment and Finance for TB
From TB control to integrated respiratory disease control
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Cheng shiming National TB Center in China May,3, 2004
5th DEWG meeting Conclusions
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Current status – (1) Achievements Building strong political commitment
Comprehensive M&E Systems
Pharmacy Sector SECTOR COMMITMENT TO END TB
Monitoring and Evaluation: A Review of Terms
Belize Presentation Dr. Ines Mendez-Moguel
Presentation transcript:

Lessons learned from Hospital DOTS Linkage (HDL) in Yogyakarta Indonesia Jan Voskens MPH, KNCV GTI/UAB

Efforts to achieve quality DOTS expansion in Government and Private Hospital sector in Indonesia

Trend New Smear Positives & All Cases, NTP Indonesia Data NTP Indonesia

Need for Acceleration % CDR %

? ? PIOT MODEL notified cure notified cases Reported notified cure Cured PIOT MODEL Treated notified cases Diagnosed ? ? Sputum examined hospitals / Lung clinics Private sector Health Centers (Puskesmas) Patients with access to health services Patients aware of their disease Total of new smear positive cases: Real Incidence

Indonesia Country situation Population 213 Million Islands 17,000 Provinces 30 Districts 357 60 % of population lives in 7 % of total land area (Java) Health Centers 7,200 Hospitals 1,100 Indonesia Country situation Yogyakarta

“Uncontrolled” DOTS expansion, 1996-200? (Inter-) national ‘’push’’ for rapid DOTS expansion in Indonesia. Were targets rational ? , feasible ? Separate systems : Health Centers – Hospitals – Private Sector Hospitals were flooded with TB drugs without proper preparation (human resource development, laboratory etc) Hospitals were poorly equipped for DOT.

Case detection in a sample of 18 hospitals in 4 provinces , 2002 Detected (all cases) New SS+ Relaps New SS – Extra Pulm. East Java (8) 5.993 32 % < 1 % 67 % 1 % Central Java (3) 6.228 9 % < 0.1 % 91 % 0.5 % Jakarta (6) 761 31 % 5 % 60 % 3 % W Kal (1) 477 53 % 45 % NTP 152.201 49 % 2 % 47 %

Treatment Results of NEW SS + in a sample of 18 hospitals in 3 provinces Jan-June 2002. East Java Central Java West Kalimantan NTP (2001) Case Finding 3.476 399 328 56.705 DOTS Eval. 1.075 37 154 Conversion 46 % 3 % 1 % 71 % Cure 40 % 0 % 2 % 74 % Completion 31 % 24 % 17 % Default 27 % 73 % 94 % 6 %

Treatment Performance of 18 Hospitals in 3 provinces, Indonesia (1st half 2002)

Case detection EAST JAVA Hospitals 2002 DOTS Ev New SS (+) Relaps New SS (-) E.P Sutomo Hosp 1.310 29 % <1 % 68 % 3 % Nganjuk Hos 130 39 % 60 % Batu L.Hosp 1.373 69 % 31 % Dungus L.H 273 22% 77 % 1 % Jember L.H 1.004 > 99 % Madiun LC 154 13 % 87 % Pemakaran 801 32 % Surabaya LC 948 22 % 2 % 75 % Total 5.993 < 1 % 67 % <1 %

Treatment results New SS+ 8 hospitals East Java (Q1-2, 2002)

The Hospital DOTS and Linkage (HDL) project in Yogyakarta, Effort to “controlled” DOTS expansion Aim : to expand DOTS coverage in Yogyakarta through linkage of government and private hospitals within the National Tuberculosis Control Program. HDL is supported by KNCV , in collaboration with GTI, USAID, WHO Started in 1999

Objectives of the HDL project: TB control network through integration of government -and private hospitals into NTP Referral link between these hospitals and government health centres

Objectives of the HDL project: Improved diagnosis of TB (laboratory network and Quality Assurance established) Improved reporting: uniform TB surveillance system established.

Strategies of the Hospital DOTS Linkage: Stepwise approach : expansion only when targets (Conversion and Cure) were met (9 20 30 hospitals) Human resource development as priority (training and supervision) Uniform Surveillance. Networking and coordination (?) Referral system (?)

Results of HDL Progress was slower then expected, due to: decentralisation and its implications high turn over of trained staff in HC’s constraints in management capacity ‘’culture’’ differences ‘’private’’ ‘’public’’

Findings (1) Involvement of hospitals has greatly increased Case Notification (CNR) of Smear positive patients in Yogya: More then 400 % increase over a period of 3 years. Linkage has drastically improved (referral, surveillance) after difficult start. (see later)

Findings (2) The HDL experience in Yogyakarta has provided ample evidence base and directions for further DOTS expansion in hospital and private sector involvement. In general great enthusiasm and willingness to introduce DOTS in hospitals.

Findings (3) In general hospitals are strong in diagnosis of cases (strong potential for direct smear miscroscopy) However hospitals are weaker in case holding and treatment supervision (compared to health centers).

“resistance to change’’ Findings (4) The change from NON-DOTS DOTS in hospitals requires considerable energy and time due to: “resistance to change’’

“resistance to change’ Findings (5) “resistance to change’ Reluctance to accept DOTS (specialists have their own interpretation) “Clinical’’ versus ‘’Public Health’’ approach: In many hospitals D.O.T is NOT consistent with the national guidelines: Lack of regular treatment supervision endangers treatment compliance.

Findings (6) There is a considerable risk that UNCONTROLLED DOTS EXPANSION in hospitals (poor treatment observation and high default rate ) is currently generating MDR on a large scale It is crucial to ensure quality DOT (proper diagnosis & supervised treatment) in hospitals.

Conclusion The NTP needs to define sound national policies and guidelines (based om evidence) to regulate the involvement (role and functions) of hospitals and private sector in the NTP Expansion to hospital and private sector should be stepwise

First steps: Start first with hospital sector (before P.S.) Sensitize hospital management to get their commitment to accept DOTS Make MoU to clarify roles and responsibilities of the private / government hospitals

MoU NTP to provide free TB drugs & other resources (lab supplies/ equipment, TB funds) only to hospitals that : are committed to follow the national DOTS guidelines (smear microscopy and proper treatment supervision) provide free diagnostic and treatment services (exempted from user fees)

Second step: Preparing hospitals Train medical staff, nurses, lab, rec staff. etc Build coordination team within hospital Establish a DOTS unit in each Hospital Introduce standard NTP Recording and Reporting formats.

Third step: build the link A strong interface between Hospitals and Public Health Services (Provincial DOTS Committee) is essential for an effective linkage . This “coordinating mechanism’’ is indispensable for successful referral

Professional Organisa-tions G E R D U N A S DI Yogyakarta HOSPITAL ASSOCIATION PERSI P R O V I N C I A L H E A L T H S E R V I C E S Hospital Districts Health Centers Professional Organisa-tions NTP GORGAS UAB KNCV PROVINCIAL D O T S C O M M I T T E

Elements of the link Provincial DOTS Committee (including representatives from hospitals and public health services), Full-time referral coordinator within the Provincial DOTS Committee, Referral register Monthly meetings for coordination between hospitals and district health services, and Direct communication by telephone/SMS for referral and tracing.

Referral system (1) In principle all routine (uncomplicated ) TB cases detected in hospitals should be referred and treated in the health facility (preferably health center ) which is nearest to the home of the patient. this to enable regular monitoring of treatment and timely tracing of defaulters

Options for TB patients diagnosed in hospitals

Referral system (2): The referral coordinator at provincial level - registers the referral and - notifies the receiving district supervisor directly by telephone / SMS. Confirmation of referral: The receiving unit gives feedback to the referral coordinator. Monthly coordination meeting to follow-up and confirm the outcome of each referral between health units or districts

In Provincial DOTS Committee ‘’Receiving’’ district Supervisor Referral Coordinator In Provincial DOTS Committee Notification of referral feedback ‘’Receiving’’ district Supervisor Receiving Unit e.g. Puskesmas B Referring Unit (e.g. Hospital A)

Implications for NTP : Potential contribution of hospitals to CDR in Indonesia Variation between 20 – 900 SS+ cases / hospital / year Assume: average is 100 SS+ cases / hospital / year (50-150) Potential yield in SS+ Cases between : 1.100 x 50 = 55 .000 , and 1.100 x 150 = 165.000 cases / year Which is 20 – 60% of total estimated SS+ incidence in Indonesia !

Involve hospitals and private sector but BE PRUDENT and CAREFUL !!!

Treatment results EAST JAVA Hospitals new SS + (1st half 2002) Lung clinic All Cases SS+ Eva- luated Conver ted Cured Treatm. compl Lost Sutomo Hosp 764 231 36% 8 % 47 % 44 % Nganjuk Hos 95 25 94 % 96 % 4 % Batu L.Hosp 685 489 46 % 58% 38 % 3 % Dungus L.H 142 44 97 % 80 % 0 % 18 % Jember L.H 783 2 100 % Madiun LC 66 7 57 % 43 % Pamekasan 440 190 24 % 10 % 45 % Surab. L.C 501 87 36 % 29 % Total 3.476 1.075 40 % 27 %